The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Clinical Trial Management (CTM)-Global Market Insights and Sales Trends 2024

Clinical Trial Management (CTM)-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1820173

No of Pages : 112

Synopsis
A Clinical Trial Management System (CTMS) is a software system used by biotechnology and pharmaceutical industries to manage clinical trials in clinical research.
The global Clinical Trial Management (CTM) market size is expected to reach US$ 1602.2 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Clinical Trial Management (CTM) in various end use industries. The expanding demands from the Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations and Healthcare Providers,, are propelling Clinical Trial Management (CTM) market. Web-based CTMS, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the On-premise segment is estimated at % CAGR for the next seven-year period.
Global Clinical Trial Management System key players include Oracle, Medidata Solutions, PAREXEL, IBM, etc. Global top four manufacturers hold a share nearly 40%.
North America is the largest market, with a share about 50%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Enterprise CTMS is the largest segment, with a share over 70%. And in terms of application, the largest application is Pharmaceutical and Biopharmaceutical Companies, followed by Clinical Research Organizations, etc.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Clinical Trial Management (CTM), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Clinical Trial Management (CTM) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Clinical Trial Management (CTM) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Clinical Trial Management (CTM) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Clinical Trial Management (CTM) covered in this report include Medidata Solutions, Parexel, BioClinica, Bio-Optronics, IBM, MedNet Solutions, Veeva Systems, Forte Research Systems and Merge Healthcare Incorporated, etc.
The global Clinical Trial Management (CTM) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medidata Solutions
Parexel
BioClinica
Bio-Optronics
IBM
MedNet Solutions
Veeva Systems
Forte Research Systems
Merge Healthcare Incorporated
Mednet Solutions
Arisglobal
eClinForce
DZS Software Solutions
DSG
Guger Technologies
ICON
ChemWare
iWeb Technologies Limited
Global Clinical Trial Management (CTM) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Clinical Trial Management (CTM) market, Segment by Type:
Web-based CTMS
On-premise
Cloud-based CTMS
Global Clinical Trial Management (CTM) market, by Application
Pharmaceutical and Biopharmaceutical Companies
Clinical Research Organizations
Healthcare Providers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Clinical Trial Management (CTM) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Clinical Trial Management (CTM)
1.1 Clinical Trial Management (CTM) Market Overview
1.1.1 Clinical Trial Management (CTM) Product Scope
1.1.2 Clinical Trial Management (CTM) Market Status and Outlook
1.2 Global Clinical Trial Management (CTM) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Clinical Trial Management (CTM) Market Size by Region (2018-2029)
1.4 Global Clinical Trial Management (CTM) Historic Market Size by Region (2018-2023)
1.5 Global Clinical Trial Management (CTM) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Clinical Trial Management (CTM) Market Size (2018-2029)
1.6.1 North America Clinical Trial Management (CTM) Market Size (2018-2029)
1.6.2 Europe Clinical Trial Management (CTM) Market Size (2018-2029)
1.6.3 Asia-Pacific Clinical Trial Management (CTM) Market Size (2018-2029)
1.6.4 Latin America Clinical Trial Management (CTM) Market Size (2018-2029)
1.6.5 Middle East & Africa Clinical Trial Management (CTM) Market Size (2018-2029)
2 Clinical Trial Management (CTM) Market by Type
2.1 Introduction
2.1.1 Web-based CTMS
2.1.2 On-premise
2.1.3 Cloud-based CTMS
2.2 Global Clinical Trial Management (CTM) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Clinical Trial Management (CTM) Historic Market Size by Type (2018-2023)
2.2.2 Global Clinical Trial Management (CTM) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Clinical Trial Management (CTM) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Clinical Trial Management (CTM) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Clinical Trial Management (CTM) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Clinical Trial Management (CTM) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Clinical Trial Management (CTM) Revenue Breakdown by Type (2018-2029)
3 Clinical Trial Management (CTM) Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical and Biopharmaceutical Companies
3.1.2 Clinical Research Organizations
3.1.3 Healthcare Providers
3.2 Global Clinical Trial Management (CTM) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Clinical Trial Management (CTM) Historic Market Size by Application (2018-2023)
3.2.2 Global Clinical Trial Management (CTM) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Clinical Trial Management (CTM) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Clinical Trial Management (CTM) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Clinical Trial Management (CTM) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Clinical Trial Management (CTM) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Clinical Trial Management (CTM) Revenue Breakdown by Application (2018-2029)
4 Clinical Trial Management (CTM) Competition Analysis by Players
4.1 Global Clinical Trial Management (CTM) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Clinical Trial Management (CTM) as of 2022)
4.3 Date of Key Players Enter into Clinical Trial Management (CTM) Market
4.4 Global Top Players Clinical Trial Management (CTM) Headquarters and Area Served
4.5 Key Players Clinical Trial Management (CTM) Product Solution and Service
4.6 Competitive Status
4.6.1 Clinical Trial Management (CTM) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Medidata Solutions
5.1.1 Medidata Solutions Profile
5.1.2 Medidata Solutions Main Business
5.1.3 Medidata Solutions Clinical Trial Management (CTM) Products, Services and Solutions
5.1.4 Medidata Solutions Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.1.5 Medidata Solutions Recent Developments
5.2 Parexel
5.2.1 Parexel Profile
5.2.2 Parexel Main Business
5.2.3 Parexel Clinical Trial Management (CTM) Products, Services and Solutions
5.2.4 Parexel Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.2.5 Parexel Recent Developments
5.3 BioClinica
5.3.1 BioClinica Profile
5.3.2 BioClinica Main Business
5.3.3 BioClinica Clinical Trial Management (CTM) Products, Services and Solutions
5.3.4 BioClinica Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.3.5 Bio-Optronics Recent Developments
5.4 Bio-Optronics
5.4.1 Bio-Optronics Profile
5.4.2 Bio-Optronics Main Business
5.4.3 Bio-Optronics Clinical Trial Management (CTM) Products, Services and Solutions
5.4.4 Bio-Optronics Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.4.5 Bio-Optronics Recent Developments
5.5 IBM
5.5.1 IBM Profile
5.5.2 IBM Main Business
5.5.3 IBM Clinical Trial Management (CTM) Products, Services and Solutions
5.5.4 IBM Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.5.5 IBM Recent Developments
5.6 MedNet Solutions
5.6.1 MedNet Solutions Profile
5.6.2 MedNet Solutions Main Business
5.6.3 MedNet Solutions Clinical Trial Management (CTM) Products, Services and Solutions
5.6.4 MedNet Solutions Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.6.5 MedNet Solutions Recent Developments
5.7 Veeva Systems
5.7.1 Veeva Systems Profile
5.7.2 Veeva Systems Main Business
5.7.3 Veeva Systems Clinical Trial Management (CTM) Products, Services and Solutions
5.7.4 Veeva Systems Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.7.5 Veeva Systems Recent Developments
5.8 Forte Research Systems
5.8.1 Forte Research Systems Profile
5.8.2 Forte Research Systems Main Business
5.8.3 Forte Research Systems Clinical Trial Management (CTM) Products, Services and Solutions
5.8.4 Forte Research Systems Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.8.5 Forte Research Systems Recent Developments
5.9 Merge Healthcare Incorporated
5.9.1 Merge Healthcare Incorporated Profile
5.9.2 Merge Healthcare Incorporated Main Business
5.9.3 Merge Healthcare Incorporated Clinical Trial Management (CTM) Products, Services and Solutions
5.9.4 Merge Healthcare Incorporated Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.9.5 Merge Healthcare Incorporated Recent Developments
5.10 Mednet Solutions
5.10.1 Mednet Solutions Profile
5.10.2 Mednet Solutions Main Business
5.10.3 Mednet Solutions Clinical Trial Management (CTM) Products, Services and Solutions
5.10.4 Mednet Solutions Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.10.5 Mednet Solutions Recent Developments
5.11 Arisglobal
5.11.1 Arisglobal Profile
5.11.2 Arisglobal Main Business
5.11.3 Arisglobal Clinical Trial Management (CTM) Products, Services and Solutions
5.11.4 Arisglobal Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.11.5 Arisglobal Recent Developments
5.12 eClinForce
5.12.1 eClinForce Profile
5.12.2 eClinForce Main Business
5.12.3 eClinForce Clinical Trial Management (CTM) Products, Services and Solutions
5.12.4 eClinForce Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.12.5 eClinForce Recent Developments
5.13 DZS Software Solutions
5.13.1 DZS Software Solutions Profile
5.13.2 DZS Software Solutions Main Business
5.13.3 DZS Software Solutions Clinical Trial Management (CTM) Products, Services and Solutions
5.13.4 DZS Software Solutions Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.13.5 DZS Software Solutions Recent Developments
5.14 DSG
5.14.1 DSG Profile
5.14.2 DSG Main Business
5.14.3 DSG Clinical Trial Management (CTM) Products, Services and Solutions
5.14.4 DSG Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.14.5 DSG Recent Developments
5.15 Guger Technologies
5.15.1 Guger Technologies Profile
5.15.2 Guger Technologies Main Business
5.15.3 Guger Technologies Clinical Trial Management (CTM) Products, Services and Solutions
5.15.4 Guger Technologies Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.15.5 Guger Technologies Recent Developments
5.16 ICON
5.16.1 ICON Profile
5.16.2 ICON Main Business
5.16.3 ICON Clinical Trial Management (CTM) Products, Services and Solutions
5.16.4 ICON Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.16.5 ICON Recent Developments
5.17 ChemWare
5.17.1 ChemWare Profile
5.17.2 ChemWare Main Business
5.17.3 ChemWare Clinical Trial Management (CTM) Products, Services and Solutions
5.17.4 ChemWare Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.17.5 ChemWare Recent Developments
5.18 iWeb Technologies Limited
5.18.1 iWeb Technologies Limited Profile
5.18.2 iWeb Technologies Limited Main Business
5.18.3 iWeb Technologies Limited Clinical Trial Management (CTM) Products, Services and Solutions
5.18.4 iWeb Technologies Limited Clinical Trial Management (CTM) Revenue (US$ Million) & (2018-2023)
5.18.5 iWeb Technologies Limited Recent Developments
6 North America
6.1 North America Clinical Trial Management (CTM) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Clinical Trial Management (CTM) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Management (CTM) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Clinical Trial Management (CTM) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial Management (CTM) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Clinical Trial Management (CTM) Market Dynamics
11.1 Clinical Trial Management (CTM) Industry Trends
11.2 Clinical Trial Management (CTM) Market Drivers
11.3 Clinical Trial Management (CTM) Market Challenges
11.4 Clinical Trial Management (CTM) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’